Abstract
Continuous ambulatory peritoneal dialysis (CAPD) is now established as a major modality for the management of chronic renal failure1. It has proved suitable as a medium-term treatment for the majority of patients, and as a long-term treatment for those patients for whom haemodialysis is either impracticable or contra-indicated including the young, elderly and those with diabetes mellitus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gokal, R. (1986). World wide experience, cost effectiveness and future of CAPD–its role in renal replacement therapy. In Gokal, R. ed Continuous Ambulatory Peritoneal Dialysis, pp. 349–69. ( Edinburgh: Churchill Livingstone )
Gokal, R., Ramos, J. M., Francis, D. M. A., et al (1982). Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet, 2, 1388–91
Editorial. (1982). Ambulatory peritonitis. Lancet, 1, 1105
Fenton, S. S. A. (1983). Peritonitis-related deaths among CAPD patients. Perlt. Dial. Bull., 3 (Suppl), S9 - S11
Pierratos, A. (1984). Peritoneal dialysis glossary. Perlt. Dial. Bull., 4, 2–3
Prowant, B. F., Nolph, K. D. (1981). Clinical criteria for diagnosis of peritonitis. In Atkins, R. C., Thomson, N. M., Farrell, P. C., eds Peritoneal Dialysis, pp. 25763. ( Edinburgh: Churchill Livingstone )
Rubin, J., Rogers, W. A., Taylor, H. M., et al (1980). Peritonitis during continuous ambulatory peritoneal dialysis. Ann. Int. Med., 92, 7–13
Parsons, F. M., Ahmed-Jushuf, I. H., Brownjohn, A. M., et al (1983). CAPD peritonitis. Lancet, 1, 348–49
Holmes, C. J., Allwood, M. C. (1977). The potential for contamination of intravenous infusion by airborne skin scales. J. Hyg., 79, 417–23
Slingeneyer, A., Mion, C., Beraud, J. J., Oules, R., Branger, B., Balmes, M. (1981). Peritonitis, a frequently lethal complication of intermittent and continuous ambulatory peritoneal dialysis. Proc. Eur. Dial. Transplant Assoc., 18, 212–21
Chan, M. K., Baillod, R. A., Chuah, P., (1981). Three years’ experience of continuous ambulatory peritoneal dialysis. Lancet, 1, 1409–12
Fenton, P. (1982). Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. J. Clin. Pathol., 35, 1181–84
Knight, K. R., Polak, A., Crump, J., Maskell, R. (1982). Laboratory diagnosis and oral treatment of CAPD peritonitis. Lancet, 2, 1301–04
Beardsworth, S. F., Goldsmith, H. J., Whitfield, E. (1983). CAPD peritonitis. Lancet, 1, 348
Pancorbo, S., Comty, C. (1983). Pharmacokinetics of cefamandole in patients undergoing continuous ambulatory peritoneal dialysis. Perit. Dial. Bull., 3, 135–37
Paton, T. W., Manuel, A., Cohen, L. B., Walker, S. E. (1983). The disposition of cefazolin and tobramycin following intraperitoneal administration in patients on continuous ambulatory peritoneal dialysis. Perit. Dial. Bull., 3, 73–76
Johnson, C. A., Welling, P. G., Zimmerman, S. W. (1984). Pharmacokinetics of oral cephradine in continuous peritoneal dialysis patients. Nephron, 38, 57–61
Neilson, H. E., Sorensen, I., Hansen, H. E. (1979). Peritoneal transport of vancomycin during peritoneal dialysis. Nephron, 24, 247–77
Bint, A. J., Gokal, R. Paton, K. R., Sornes, S., Ward, M. K. (1980). Peritonitis in continuous ambulatory peritoneal dialysis: laboratory and clinical studies with cefuroxime. In Cefuroxime Update: Royal Society of Medicine International Congress and Symposium Series No 38, pp. 173–79. ( London: Academic Press )
Local, F. K., Munro, A. J., Kerr, D. N. S., Sussman, M. (1981). Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis. Clin. Nephrol., 16, 40–43
Oreopoulos, D. G., Williams, P., Khanna, R., Vas, S. (1981). Treatment of peritonitis. Perit. Dial. Bull., 1, (Suppl), S17 - S19
Glew, R. H., Pavuk, R. A., Shuster, A., Alfred, H.J. (1982). Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis. Int. J. Clin. Pharmacol. Ther. Toxicol., 20, 559–63
Keogh, J. A. B., Carr, M. E., Falkiner, F. R., Martin, P., Grant, G., Keane, C. T. (1983). Pharmacokinetics of netilmicin in CAPD patients. Perit. Dial. Bull., 3, 172–75
Manuel, M. A., Paton, T. W., Cornish, W. R. (1983). Drugs and peritoneal dialysis. Perit. Dial. Bull., 3, 117–25
Sewell, D. L., Golper, T. A., Brown, S. D., Nelson, E., Knower, M., Kimbrough, R. C. (1983). Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin. Am. J. Kidney Dis., 3, 209–12
Smith, C. R., Lipsky, J. J., Laskin, O. L., et al (1980). Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N. Engl. J. Med., 302, 1106–09
Lerner, A. M., Reyes, M. P., Cone, L. A., et al (1983). Randomised, controlled trial of the comparative efficacy, auditory toxicity and nephrotoxicity of tobramycin and netilmicin. Lancet, 1, 1123–26
Davies, A. J., Dyas, A. (1985). Antimicrobial susceptibility of Staphylococcus epidermidis and Staph. aureus. J. Antimicrob. Chemother., 15, 127–28
Richardson, J. F., Marples, R. R. (1982). Changing resistance to antimicrobial drugs, and resistance typing in clinically significant strains of Staphylococcus epidermidis. J. Med. Microbiol., 15, 475–84
Gruer, L. D., Bartlett, R., Ayliffe, G. A. F. (1984). Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. J. Antimicrob. Chemother., 13, 577–83
Atkins, R. C., Humphrey, T., Thomson, N., Hooke, D., Williamson, J., Davidson, A. (1981). Efficacy of treatment in CAPD peritonitis–the problem of staphylococcal antibiotic resistance. In Atkins, R. C., Thomson, N. M., Farrell, P. C., eds Peritoneal Dialysis, pp. 333–39. ( Edinburgh: Churchill Livingstone )
Leung, A. C. T., Orange, G., Henderson, I. S., Sleigh, J. D. (1984). Successful use of combined intraperitoneal azlocillin and aminoglycoside in the treatment of dialysis associated Pseudomonas peritonitis. Petit. Dial. Bull., 4, 98–101
Garrod, L. P., Lambert, H.P., O’Grady, F. (1981). Antibiotic and Chemotherapy, 5th edn., pp. 234–36. ( Edinburgh: Churchill Livingstone )
Gray, H. H., Goulding, S., Eykyn, S. J. (1985). Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis. Clin. Nephrol., 23, 81–84
Vas, S. I. (1982). Aetiology and diagnosis of peritonitis in peritoneal dialysis patients. In La Greca G., Biasiol, S., Ronco, C., eds Peritoneal Dialysis, pp. 31968. Proceedings of the first international course on dialysis. Vicenza, Italy, 1982. ( Milan: Wichtig Editore )
Krothapalali, R., Duffy, W. B., Lacke, C., et al (1982). Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch. Intern. Med., 142, 1862–63
Locci, R., Romagnoni, M., Boccari, M., et al (1984). Massive colonisation of an indwelling catheter by Penicillium pinophilum without peritonitis. Petit. Dial. Bull., 4, 243–44
Fabris, A., Biasioli, S., Borin, D., (1984). Fungal peritonitis in peritoneal dialysis: our experience and review of treatments. Peril. Dial. Bull., 4, 75–77
Slingeneyer, A., Larochi, B. Stec, F., Canaud, B., Beraud, J.J., Mion, C. (1988). Oral ketoconazole plus intraperitoneal 5-flucytosine as the sole treatment of fungal peritonitis. In Maaher, I. F., Winchester, J. F.,Frontiers in Peritoneal Dialysis (New York: Field and Rich) (in press)
McGuire, N. M., Port, F. D., Kauffman, C. A. (1984). Ketoconazole pharmacokinetics in continuous ambulatory peritoneal dialysis. Petit. Dial. Bull., 4, 199–201
Khana, R., Fenton, S. S., Caltran, D. C., et al (1980). Tuberculous peritonitis in patients undergoing CAPD. Peril. Dial. Bull., 1, 10–12
Gokal, R., Ramos, J. M., Ward, M.K., Kerr, D. N. S. (1981). `Eosinophilic’ peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Clin. Nephrol., 15, 328–30
Salgia, P., Manos, J., Gokal, R. (1984). Cutaneous manifestations heralding eosinophilic peritonitis. Petit. Dial. Bull., 4, 265
Andreoli, S. P., West, K. W., Grosfeld, J. C., Bergstem, J. M. (1984). A technique to eradicate tunnel infection without peritoneal dialysis catheter removal. Petit. Dial. Bull., 4, 156–58
Oreopoulos, D. G. (1979). Requirements for the organization of a continuous ambulatory peritoneal dialysis program. Nephron, 24, 261–63
Slingeneyer, A., Mion, C. (1982). Peritonitis prevention in continuous ambulatory peritoneal dialysis: long-term efficacy of a bacteriological filter. Prot.. Eur. Dial. Transplant Assoc., 19, 388–96
Ash, S. R., Horswell, R., Heeter, E. M., Bloch, R. (1983). Effect of the Peridex filter on peritonitis rates in a CAPD population. Perit. Dial. Bull., 3, 89–93
Maiorca, R., Cantaluppi, A., Cancarini, G. C., Scalamogna, A., Broccoli, R., Graziani, G., Brasa, S., Ponticelli, C. (1983). Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet, 2, 642–44
Vas, S. I., Low, D. E., Oreopoulos, D. G., et al (1981). Antibiotic prophylaxis in CAPD patients. In Atkins, R. C., Thomson, N. M., Farrell, P. C. eds Peritoneal Dialysis, pp. 320–26. ( Edinburgh: Churchill Livingstone )
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bint, A.J., Pedler, S.J. (1988). Peritonitis Complicating CAPD. In: Catto, G.R.D. (eds) Continuous Ambulatory Peritoneal Dialysis. New Clinical Applications Nephrology, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7828-0_2
Download citation
DOI: https://doi.org/10.1007/978-94-011-7828-0_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-7830-3
Online ISBN: 978-94-011-7828-0
eBook Packages: Springer Book Archive